Navigation Links
Top Bristol-Myers Squibb Executive Joins Patton Boggs
Date:2/18/2010

WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- Patton Boggs LLP has hired Dick Thompson, a top executive at Bristol-Myers Squibb with nearly four decades of public policy experience, to strengthen its hand in the healthcare and pharmaceutical sectors.

Mr. Thompson joins the firm as senior counsel in its Washington office where he will utilize his extensive experience with complex health and pharmaceutical policy issues to help clients navigate a challenging political environment.

"It is a major coup to have such a highly experienced and well-respected leader like Dick Thompson join the firm," said Stuart M. Pape, managing partner of the firm. "Our clients will benefit from his deep industry connections, significant government affairs prowess and experience as an executive at a major international powerhouse like Bristol-Myers Squibb."

Mr. Thompson, known as the "Dean" of the pharmaceutical industry corporate representatives, is a respected leader in the public policy and pharmaceutical industries. He spent the past decade as Bristol-Myers Squibb's senior vice president for policy and government affairs where he established and led a 45-member global staff.

As a member of the Bristol-Myers Squibb's operating committee, Mr. Thompson represented the company to key industry associations and managed the development of major public policy positions. At the time of his retirement in December 2009, Mr. Thompson had served as head of the Washington office for more than 26 years, longer than any current or former industry executive.

During his tenure, he worked to move the company to the top tier of advocacy in the pharmaceutical industry, pioneered a new international government affairs program and led the integration of the government affairs staff in the merger of the Bristol-Myers and Squibb companies.

"Patton Boggs has long been regarded as the premier public policy firm in the country, and I am excited to join such an exalted team," Mr. Thompson said. "I look forward to utilizing my experience at Bristol-Myers Squibb to help clients from the pharmaceutical and other industries achieve their strategic business and policy objectives."

Mr. Thompson spent nearly eight years working on Capitol Hill, including three years as Republican staff director and chief counsel to what is now known as the House Committee on Government Oversight and Reform.

Mr. Thompson moved to Washington in 1970 after serving two years in the U.S. Army, including a tour in Vietnam where he earned the rank of captain.

Mr. Thompson is active in many charitable and civic organizations. He is a vice chairman and trustee of Syracuse University, where he received his master's degree from the Maxwell School of Citizenship and Public Affairs. In addition, he has served as the president and a board member of the Carlton Club, chair of Ford Theatre's board of trustees and as chair of the governance committee and a member of the board of directors of Meridian International Center. He serves as a member of the Federal City Council.

Patton Boggs LLP

Based in Washington, D.C., Patton Boggs is a leader in public policy, litigation, and business law, and is well known for its deep bipartisan roots in the U.S. political arena. The firm's core practice areas are Public Policy and Regulatory, Litigation, Business, and Intellectual Property. With offices in New York, New Jersey, Dallas, Denver, Anchorage, Northern Virginia and internationally in Doha, Qatar and Abu Dhabi, United Arab Emirates, more than 600 lawyers and professionals provide comprehensive, practical and cost-effective legal counsel to clients around the globe. For more information, visit us at www.pattonboggs.com. To receive press releases from Patton Boggs, please contact Rebecca Carr at rcarr@pattonboggs.com.

SOURCE Patton Boggs LLP

RELATED LINKS
http://www.pattonboggs.com

'/>"/>

SOURCE Patton Boggs LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
2. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
3. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
4. Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board
5. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
6. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
7. Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year and Company Named Sixteenth Fastest Growing Company
8. Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President
9. Cardinal Health Executives to Speak at Two Investor Events in January
10. New Executive Leadership and CEO Announced for BiPar Sciences
11. Ascension Orthopedics Hires Key Senior Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , February 23, 2017 ... report on the global market for intraoperative imaging, ... presently valued at US$ 513.9 million. According to ... keep surging on the grounds of increasing adoption ... the field of diagnostic imaging for neurosurgeries. The ...
(Date:2/23/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Cardiac Prosthetic Devices ... over the next decade to reach approximately $8.9 billion by 2025. ... for all the given segments on global as well as regional ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology:
(Date:2/23/2017)... Cranbury, NJ (PRWEB) , ... February 23, 2017 ... ... Cure®, the pre-eminent publication and community for those in the fight against cancer, ... was important in their success. HRA will release top-line findings in a ...
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only nursing quality ... conference – Empowerment, Value and Collaboration – in Seattle, WA on October 23, 2017. ... Mason Health System in Seattle since 2000. In addition to his role at Virginia ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing ... sit stand solutions representative to the Minneapolis Home and Garden Show which is being ... that is garnering national attention is the Minneapolis Convention Center. , From its ...
(Date:2/22/2017)... East Setauket, New York (PRWEB) , ... February ... ... the main floor entrance and lobby of a new healthcare contact center in ... gleaming results. , One of the nation’s largest healthcare systems recently invested $51 ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy ... The technology is so cutting edge, in fact, the U.S. Food and Drug ... procedures. However, successful patient outcomes in certain clinical stem cell procedures have shown ...
Breaking Medicine News(10 mins):